I'm not even thinking of covering until this is under $1
This will suffer the same fate as that ELN's drug. So, there is nothing for me to worry about here.
Sentiment: Strong Sell
Elan's drug, Tysabri, is back on the market. It took about a year and a half for that to happen. Sre you suggesting the same thing will happen with Omontys?